Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrating Transcranial Magnetic Stimulation as a Treatment for Nicotine Dependence in the Clinic
NCT06534047Phase 4Recruiting
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) and nicotine dependence (2 arms), sponsored by Center for Addiction and Mental Health. Primary endpoint: Feasibility of conducting a pragmatic, hybrid effectiveness implementation trial at 2 years. Started Sep 2024; status: recruiting.
02
Conditions
Tobacco Use Disorder (TUD)nicotine dependence
Beyond the preview
Go deeper on NCT06534047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06534047.